GenVault

corporate

corporate » intellectual property

European patent 1449147. November 6, 2009
GenVault Corporation granted new European patent #1449147 for biosample management technologies. This patent relates to an “Archive and analysis system” that provides a method for archiving and retrieving biological, or non-biological, samples maintained in a desiccated form at multiple nodes on a carrier.

This European patent, together with previously awarded US and Japanese patents, serves to further strengthen GenVault Corporation’s broad, exclusive, intellectual property coverage in support of its core business globally: the development and commercialization of consumables, hardware and software for the acquisition, storage and recovery of biological specimens preserved in the dried solid state, for the creation of biobanks or biorepositories.



Japanese patent 4350516. November 4, 2009

GenVault Corporation granted new Japanese patent #4350516 for biosample management technologies covering, “Sample carrier comprising a structural array for archiving sample material.”



September 15, 2009.
GenVault Corporation granted two new U.S. patents for biosample management technologies.

The of first of these awarded on September 1st 2009  (US #7,584,240) corresponds to a patent that covers “Automated Biological Sample Archives for Storage, Retrieval & Analysis of a Large Number of Samples for remote clients”. As part of GenVault’s patent portfolio this latest patent complements the previously awarded US Patent #7,142,987, that covered GenVault’s rights to dry state sample archiving.

The second patent awarded to GenVault on September 15th 2009 (US#7,589,184) corresponds to a patent covering “Stable protein storage and stable nucleic acid storage in recoverable form.” This patent protects GenVault’s right to use novel matrices for the stabilization of biospecimens in the air-dried state. This exclusive intellectual property coverage will support a range of newly developed products based on biospecimen stabilization in engineered sponge and similar materials. These new “elastomeric” matrices will enable the replacement of filter
paper, swabs and a number of other existing matrices, for the collection, shipping and storage of
biospecimens, especially in the fields of public health and personalized medicine.

 

U.S.Patent 7,589,184. September 15, 2009
"Stable protein storage and stable nucleic acid storage in recoverable form"
The invention provides compositions and methods for storage of biomolecules. The biomolecules are stored via absorption to a substrate. Absorbed biomolecules can be eluted or recovered from the substrate at a future time, and optionally be subjected to a subsequent analysis or application. Biomolecules absorbed to a substrate for storage may also optionally be preserved, i.e., the absorbed biomolecule is resistant to or resists degradation.



U.S. Patent 7,584,240. September 1, 2009
Automated biological sample archive for storage, retrieval and analysis of large numbers of samples for remote clients
Systems and methods of providing biological and non-biological samples, as well as selected analyses thereof, to a remote client are disclosed. In some embodiments, such systems and methods include some or all of the following: maintaining a sample archive comprising a plurality of discrete sample nodes; receiving a request for a sample or an analysis thereof from a remote client, the request including identification of a selected sample node from the plurality of discrete sample nodes and identification of a selected assay; retrieving the selected sample node from the archive; preparing the selected assay; and performing the selected assay for the selected sample node. As noted above, samples and results of analyses may be transmitted to the remote client. In some embodiments, a system and method may retrieve, prepare, and package in excess of 100, 200, or 500 samples per day.

Click here to view the press release.

GenVault has been awarded U.S. patent #7,142,987 giving GenVault broad rights to dry state sample archiving, using carriers designed to store dried biosamples as discrete, individually addressable aliquots in a predetermined spatial relationship. This patent allows GenVault broad coverage to exclusively develop and market consumables for dry-state biosample storage. This patent also covers the generalized use of hardware for organizing the storage of such dry-state sample aliquots to form sample archives. Finally, the patent covers the generalized use of software to track the location, use-history and the data associated with such individually addressable dry state samples, in the context of organized sample management and archiving.

Further, GenVault has recently acquired the exclusive rights to novel nucleic acid labeling technology. In addition, ten more U.S. patent applications and a similar number of foreign applications have been filed to cover GenVault's unique dry-state biosample management systems and processes.

Specific components of the integrated biosample management systems include:

            • ambient temperature chemistry allowing the elution of double-stranded DNA from the dry-state elements
            • biological bar code allowing absolute traceability of the biosamples at all tim
            • electronic micro-device tagging of biosamples
            • machine stacking devices and procedures allowing very high density storage

          New patent applications in process include chemistries for the preservation of proteins in the dry-state.

#7,142,987 hyperlink to: Press News Release from December 19, 2006

exclusive rights hyperlink to: Press article from May 11, 2005